Dong Gyu Lee1, Sung-Il Jang2, Young-Rang Kim1, Kyeong Eun Yang1, So Jung Yoon1,3, Zee-Won Lee1, Hyun Joo An4, Ik-Soon Jang1, Jong-Soon Choi5,6, Hwa-Seung Yoo2. 1. Division of Life Science, Korea Basic Science Institute, Daejeon, 305-333, Korea. 2. East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University, Daejeon, 302-122, Korea. 3. Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, 305-764, Korea. 4. Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, 305-764, Korea. altyhs@dju.kr. 5. Division of Life Science, Korea Basic Science Institute, Daejeon, 305-333, Korea. jschoi@kbsi.re.kr. 6. Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, 305-764, Korea. jschoi@kbsi.re.kr.
Abstract
OBJECTIVE: To investigate the effect of three major ginsenosides from mountain ginseng as anticancer substance and explore the underlying mechanism involved in lung cancer. METHODS: The inhibitory proliferation of lung cancer by major five ginsenosides (Rb1, Rb2, Rg1, Rc, and Re) was examined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. Calculated 50% inhibition (IC50) values of five ginsenosides were determined and compared each other. Apoptosis by the treatment of single ginsenoside was performed by fluorescence-assisted cytometric spectroscopy. The alterations of apoptosis-related proteins were evaluated by Western blot analysis. RESULTS: The abundance of ginsenosides in butanol extract of mountain ginseng (BX-MG) was revealed in the order of Rb1, Rg1, Re, Rc and Rb2. Among them, Rb1 was the most effective to lung cancer cell, followed by Rb2 and Rg1 on the basis of relative IC50 values of IMR90 versus A549 cell. The alterations of apoptotic proteins were confirmed in lung cancer A549 cells according to the administration of Rb1, Rb2 and Rg1. The expression levels of caspase-3 and caspase-8 were increased upon the treatment of three ginsenosides, however, the levels of caspase-9 and anti-apoptotic protein Bax were not changed. CONCLUSION: Major ginsenosides such as Rb1, Rb2 and Rg1 comprising BX-MG induced apoptosis in lung cancer cells via extrinsic apoptotic pathway rather than intrinsic mitochondrial pathway.
OBJECTIVE: To investigate the effect of three major ginsenosides from mountain ginseng as anticancer substance and explore the underlying mechanism involved in lung cancer. METHODS: The inhibitory proliferation of lung cancer by major five ginsenosides (Rb1, Rb2, Rg1, Rc, and Re) was examined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. Calculated 50% inhibition (IC50) values of five ginsenosides were determined and compared each other. Apoptosis by the treatment of single ginsenoside was performed by fluorescence-assisted cytometric spectroscopy. The alterations of apoptosis-related proteins were evaluated by Western blot analysis. RESULTS: The abundance of ginsenosides in butanol extract of mountain ginseng (BX-MG) was revealed in the order of Rb1, Rg1, Re, Rc and Rb2. Among them, Rb1 was the most effective to lung cancer cell, followed by Rb2 and Rg1 on the basis of relative IC50 values of IMR90 versus A549 cell. The alterations of apoptotic proteins were confirmed in lung cancer A549 cells according to the administration of Rb1, Rb2 and Rg1. The expression levels of caspase-3 and caspase-8 were increased upon the treatment of three ginsenosides, however, the levels of caspase-9 and anti-apoptotic protein Bax were not changed. CONCLUSION: Major ginsenosides such as Rb1, Rb2 and Rg1 comprising BX-MG induced apoptosis in lung cancer cells via extrinsic apoptotic pathway rather than intrinsic mitochondrial pathway.
Entities:
Keywords:
Butanol extract of mountain ginseng; apoptosis; ginsenoside; lung cancer
Authors: Othman A AL Shabanah; Moureq rashed Alotaibi; Salim S Al Rejaie; Ali R Alhoshani; Mashal M Almutairi; Musaad A Alshammari; Mohamed M Hafez Journal: Asian Pac J Cancer Prev Date: 2016-11-01
Authors: Lan Thi Hanh Phi; Yoseph Toni Wijaya; Ita Novita Sari; Ying-Gui Yang; Yun Kyung Lee; Hyog Young Kwon Journal: Cancer Med Date: 2018-09-27 Impact factor: 4.452
Authors: Lorena Avila-Carrasco; Pedro Majano; José Antonio Sánchez-Toméro; Rafael Selgas; Manuel López-Cabrera; Abelardo Aguilera; Guadalupe González Mateo Journal: Front Pharmacol Date: 2019-07-30 Impact factor: 5.810